ROI Financial Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
ROI Financial Advisors's LLY Position: Q1 2026 in Review
ROI Financial Advisors reduced its Eli Lilly (LLY) stake by 2% in Q1 2026, selling an estimated $208K and leaving 9,848 shares worth $9.06M. The position accounts for 5.42% of the portfolio, ranked #5.
ROI Financial Advisors first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $12.5M in Q2 2024. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- ROI Financial Advisors held 9,848 shares of Eli Lilly worth $9.06M as of Q1 2026.
- ROI Financial Advisors sold 205 Eli Lilly shares in Q1 2026, an estimated $208K.
- Eli Lilly made up 5.42% of ROI Financial Advisors's portfolio in Q1 2026, its #5 holding.
- ROI Financial Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
- ROI Financial Advisors's Eli Lilly position peaked at $12.5M in Q2 2024.
- 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on ROI Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.